Company Filing History:
Years Active: 1993-1998
Title: Daniele Spehner: Innovator in Viral Vector Technology
Introduction
Daniele Spehner is a notable inventor based in Eckbolsheim, France. She has made significant contributions to the field of biotechnology, particularly in the development of viral vectors for therapeutic applications. With a total of 2 patents, her work has implications for vaccine development and gene therapy.
Latest Patents
Daniele's latest patents focus on DNA sequences, vectors, and recombinant viruses. One of her inventions involves a DNA sequence isolated from the cowpox virus, which plays a crucial role in the multiplication of this virus in CHO cells. This DNA can be incorporated into vectors and recombinant viruses, such as recombinant vaccinia viruses, which are capable of multiplying in CHO cells. Another patent involves a recombinant fowlpox virus derived from an attenuated strain, which integrates a DNA sequence coding for a heterologous protein in a non-coding intergenic region of its genome.
Career Highlights
Daniele Spehner is currently employed at Transgene S.A., a company that specializes in the development of innovative immunotherapies for cancer and infectious diseases. Her work at Transgene has allowed her to explore the potential of viral vectors in therapeutic applications, contributing to advancements in the field.
Collaborations
Daniele collaborates with Robert Drillien, who is also involved in the research and development of viral vector technologies. Their partnership enhances the innovative capacity of their projects and contributes to the success of their research endeavors.
Conclusion
Daniele Spehner's contributions to the field of biotechnology through her patents and work at Transgene S.A. highlight her role as a key innovator in viral vector technology. Her research has the potential to impact vaccine development and gene therapy significantly.